Evolus, Inc.
EOLS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.54 | 0.52 | -0.14 | 0.09 |
| FCF Yield | -2.84% | -5.95% | -20.86% | -10.60% |
| EV / EBITDA | -29.11 | -15.86 | -8.20 | -6.46 |
| Quality | ||||
| ROIC | -20.35% | -34.75% | -49.26% | -22.10% |
| Gross Margin | 68.46% | 69.54% | 60.41% | 56.32% |
| Cash Conversion Ratio | 0.36 | 0.55 | 1.14 | 0.71 |
| Growth | ||||
| Revenue 3-Year CAGR | 21.46% | 26.57% | 38.01% | 41.84% |
| Free Cash Flow Growth | 45.36% | 59.44% | -155.69% | 43.68% |
| Safety | ||||
| Net Debt / EBITDA | -1.72 | -1.52 | -0.38 | 1.83 |
| Interest Coverage | -1.84 | -3.56 | -7.18 | -31.81 |
| Efficiency | ||||
| Inventory Turnover | 6.91 | 5.60 | 3.12 | 24.71 |
| Cash Conversion Cycle | 78.06 | 95.03 | 116.65 | 17.38 |